top of page
< Back

Hydroxychloroquine


Mechanism of action:

Hydroxychloroquine is a 4-aminoquinoline derivative. Hydroxychloroquine is a weakly basic molecule that can accumulate in lysosomes and endosomes, raising their internal pH and thereby inhibiting the activity of enzymes that depend on an acidic environment. This reduces the efficiency of antigen peptide processing and MHC class II presentation, leading to weaker T cell activation. It can also inhibit Toll-like receptors (TLR7 and TLR9), reducing the release of interferons and multiple pro-inflammatory cytokines, thereby lowering chronic inflammatory responses. Hydroxychloroquine is also thought to interfere with heme detoxification-related processes within the food vacuole of Plasmodium parasites, including effects on heme polymerization/crystallization, leading to the accumulation of toxic heme and ultimately killing the malaria parasites hiding inside red blood cells.

Reference(s):

1. Lim HS et al. (2009). Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax. Antimicrob Agents Chemother. 


2. Furst DE et al. (1996). Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases. Lupus. 


3. Collins KP et al. (2018). Hydroxychloroquine: a physiologically-based pharmacokinetic model in the context of cancer-related autophagy modulation. J Pharmacol Exp Ther.

bottom of page